DIU liberador de levonorgestrel vs. tratamiento médico | 09 MAR 18

Tratamiento de la menorragia

Se observó una preferencia de las mujeres por el dispositivo intrauterino liberador de levonorgestrel sobre el tratamiento clásico.
Autor/a: Dres. Janesh Gupta, Joe Kai, Lee Middleton, Helen Pattison, Richard Gray, Jane Daniels N Engl J Med 2013;368:128-37
INDICE:  1. Artículo | 2. Referencias
Referencias

1. Frick KD, Clark MA, Steinwachs DM, et al. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Womens Health Issues 2009;19:70-8.
2. Roberts TE, Tsourapas A, Middleton LJ, et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ 2011;342:d2202.
3. Nicholson WK, Ellison SA, Grason H, Powe NR. Patterns of ambulatory care use for gynecologic conditions: a national study. Am J Obstet Gynecol 2001;184:523-30.
4. Coulter A, Bradlow J, Agass M. Outcomes of referrals to gynecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 1991;98:789-96.
5. Office of Population Census and Surveys. Morbidity statistics from general practice: fourth national morbidity study 1991-1992. London: Her Majesty’s Stationery Office, 1995.
6. Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA. Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol 2010;202(6):541.e1-541.e6.
7. Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. Surgery for menorrhagia within English regions: variation in rates of endometrial ablation and hysterectomy. BJOG 2009;116:1373-9.
8. Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol 1999;82:73-6.
9. Warner P, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems: cross sectional survey of symptoms,
reasons for referral, and management. BMJ 2001;323:24-8.
10. National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists, 2007 (guideline CG44).
11. Higham JM, O’Brien PM, Shaw RW.
Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9.
12. Santer M, Wyke S, Warner P. What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Womens Health 2007;7:8.
13. Endrikat J, Vilos G, Muysers C, Fortier M, Solomayer E, Lukkari-Lax E. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Arch Gynecol Obstet 2012;285:117-21.
14. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel- releasing intrauterine system in menorrhagia: a systematic review. BJOG 2001;108:74-86.
15. Middleton LJ, Champaneria R, Daniels JP, et al. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 2010;341:c3929.
16. The initial management of menorrhagia: evidence based guidelines no. 1. London: Royal College of Obstetricians and Gynaecologists, 1998.
17. Shaw RW, Brickley MR, Evans L, Edwards MJ. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol 1998;105:1155-9.
18. Pattison H, Daniels JP, Kai J, Gupta JK. The measurement properties of the menorrhagia multi-attribute quality-oflife scale: a psychometric analysis. BJOG 2011;118:1528-31.
19. Matteson KA, Boardman LA, Munro MG, Clark MA. Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril 2009;92:205-16.
20. Gibbons E, Mckintosh A, Fitzpatrick R. A structured review of patient-reported outcome measures for people undergoing elective procedures for benign gynaecological conditions of the uterus: report to the Department of Health. Oxford, United Kingdom: University of Oxford, 2010.
21. Habiba M, Julian S, Taub N, et al. Limited role of multi-attribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2010;148:81-5.
22. Protheroe J, Bower P, Chew-Graham C, Peters TJ, Fahey T. Effectiveness of a computerized decision aid in primary care on decision making and quality of life in menorrhagia: results of the MENTIP randomized controlled trial. Med Decis Making 2007;27:575-84.
23. Thirlaway K, Fallowfield L, Cuzick J. The Sexual Activity Questionnaire: a measure of women’s sexual functioning. Qual Life Res 1996;5:81-90. [Erratum, Qual Life Res 1997;6:606.]
24. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976;34:585-612.
25. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press, 1977. 26. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer, 2000.
27. Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley, 1987.
28. White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011;342:d40.
29. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-92.
30. Shapley M, Blagojevic M, Jordan K, Croft P. The spontaneous resolution of heavy menstrual bleeding in the perimenopausal years. BJOG 2012;119:545-53.
31. Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol 2007;47:335-40.
32. Ewies AA. Levonorgestrel-releasing intrauterine system — the discontinuing story. Gynecol Endocrinol 2009;25:668-73.
33. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-7.
34. Busfield RA, Farquhar CM, Sowter MC, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006;113:257-63.
35. Kittelsen N, Istre O. A randomized study comparing levonorgestrel intrauterine system (LNG IUS) and transcervical resection of the endometrium (TCRE) in the treatment of menorrhagia: preliminary results. Gynaecol Endosc 1998;7:61-5.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024